cyclosporine has been researched along with Uveitis in 120 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.33) | 18.7374 |
1990's | 47 (39.17) | 18.2507 |
2000's | 26 (21.67) | 29.6817 |
2010's | 36 (30.00) | 24.3611 |
2020's | 7 (5.83) | 2.80 |
Authors | Studies |
---|---|
Hasumi, Y; Ida, Y; Ishihara, M; Kawano, S; Kimura, I; Mizuki, N; Shibuya, E; Takeuchi, M; Yamane, T | 1 |
Alafaleq, M; Bodaghi, B; Deray, G; Fardeau, C; Freund, R; Isnard-Bagnis, C; LE Hoang, P; Penet, MA; Tezenas du Montcel, S; Tostivint, I | 1 |
Duan, R; Gao, Y; Li, H; Lin, X; Liu, X; Su, W; Tao, T; Wang, R; Xie, L; Yang, S | 1 |
Abu El-Asrar, AM; Albloushi, AF; Alkheraiji, NF; Almater, AI; Alromaih, AZ | 1 |
Cisło-Pakuluk, A; Marycz, K; Padjasek, M; Qasem, B | 1 |
Chen, Y; Xu, H | 1 |
Maruyama, K | 1 |
Basu, S; Damera, S; Kaza, H; Parai, D; Rana, K; Tagirasa, R | 1 |
Bähler, H; Bauer, D; Busch, M; Heiligenhaus, A; Kasper, M; Pacheco-López, G; Schedlowski, M; Schröder, M; Thanos, S; Walscheid, K; Wildschütz, L | 1 |
Bauer, D; Böhm, MRR; Busch, M; Courthion, H; Gabriel, D; Gurny, R; Heiligenhaus, A; Kasper, M; Loser, K; Möller, M; Rodriguez-Aller, M; Thanos, S; Wildschütz, L | 1 |
Guex-Crosier, Y; Ribi, C; Rossi, DC | 1 |
Abul Kalam, M; Ali, R; Alshamsan, A; Alturki, TA; Binkhathlan, Z; Lavasanifar, A; Raish, M; Safaei Nikouei, N; Vakili, MR | 1 |
Joshi, L; Lightman, S; McCluskey, P; Sandhu, S; Talat, L; Taylor, SR; Wakefield, D; Yaganti, S | 1 |
Airò, P; Cavazzana, I; Franceschini, F; Fredi, M; Nascimbeni, G; Taraborelli, M; Tincani, A | 1 |
Bascherini, V; Cantarini, L; Caso, F; Costa, L; Franceschini, R; Latronico, E; Rigante, D; Vitale, A | 1 |
Basile, L; Calafiore, S; Ciarnella, A; Guglielmelli, F; Laganà, B; Mutolo, MG; Recupero, SM; Verrilli, S | 1 |
Adán, A; Lee, RW; Llorenç, V; Mesquida, M; Molins, B; Pelegrín, L | 1 |
Deuter, C; Doycheva, D; Zierhut, M | 1 |
López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
Liu, X; Zhang, M | 1 |
Chung, YR; Lee, ES; Lee, K; Park, JY; Song, JH | 1 |
Abe, S; Ebe, H; Hagiwara, S; Hoshi, S; Kondo, Y; Kurata, I; Matsumoto, I; Ogishima, H; Oshika, T; Sumida, T; Suzuki, T; Takahashi, H; Tsuboi, H; Umeda, N | 1 |
Adan, AM; Aparicio, Á; Blanco, A; Blanco, R; Calvo-Río, V; Cordero-Coma, M; Fonollosa, A; García Serrano, JL; González-Gay, MA; González-Suárez, S; González-Vela, C; Herreras, JM; Loricera, J; Maíz, O; Mesquida, M; Ortego-Centeno, N; Peiteado-Lopez, D; Pina, T; Riancho-Zarrabeitia, L; Sánchez-Bursón, J; Santos-Gómez, M | 1 |
Basiaga, ML; Behrens, EM; Weiss, PF | 1 |
Fang, C; He, Y; Huang, C; Li, J; Lin, Z; Zhan, S; Zhou, D | 1 |
Aktas, Z; Cubuk, MO; Gurelik, G; Hasanreisoglu, B; Hasanreisoglu, M; Ozdek, S | 1 |
Jones, N | 1 |
Shalaby, U | 1 |
Gery, I | 1 |
Chan, CC; Sen, HN; Tabbara, KF | 1 |
Smith, WM | 1 |
Ganser, G; Heiligenhaus, A; Heinz, C; Michels, H; Roesel, M; Tappeiner, C | 1 |
Anglade, E; Austin, BA; Chan, CC; Cunningham, MA; Li, Z; Liu, B; Nussenblatt, RB; Velagaleti, P; Yeh, S | 1 |
Angeles-Han, S; Flynn, T; Lehman, T | 1 |
Cağil, N; Erten, S; Midillioğlu, IK; Orhan, N; Simşek, S; Yülek, F | 1 |
Kamoi, K; Kawaguchi, T; Mochizuki, M; Sugita, S; Tanaka, H; Yamada, Y | 1 |
Daniel, E; Foster, CS; Gangaputra, S; Jabs, DA; Kaçmaz, RO; Kempen, JH; Levy-Clarke, GA; Newcomb, C; Nussenblatt, RB; Rosenbaum, JT; Suhler, EB; Thorne, JE | 1 |
Deuter, CM | 1 |
Brooks, DE; Clode, AB; Gilger, BC; Komaromy, AM; McMullen, RJ; Salmon, JH; Utter, ME; Wilkie, DA | 1 |
Horie, S; Kaneko, S; Mochizuki, M; Sugita, S; Yamada, Y | 1 |
Al-Obeidan, SS; El-Asrar, AM; Geboes, K; Kangave, D; Opdenakker, G; Struyf, S; Van Damme, J | 1 |
Denniston, AK; Murray, PI; Sreekantam, S | 1 |
Chung, H; Lee, SH; Yu, HG | 1 |
Arevalo, JF; Benitez-Del-Castillo, JM; Blanco, R; Cordero-Coma, M; Díaz-Llopis, M; Fernandez-Cid, C; Fonollosa, A; Garcia-Aparicio, AM; Garcia-de-Vicuña, C; Olea, JL; Ortega, G; Ortego, N; Rio-Pardo, MJ; Salom, D; Suarez-de-Figueroa, M | 1 |
Fujino, Y; Kaburaki, T; Kawashima, H; Okinaga, K; Takamoto, M; Yoshida, A | 1 |
Heiligenhaus, A; Heinz, C; Hennig, M; Rammrath, D; Roesel, M; Zurek-Imhoff, B | 1 |
Balaskas, K; Eperon, S; Guex-Crosier, Y; Gurny, R; Rodriguez-Aller, M | 1 |
Heiligenhaus, A; Heinz, C; Hoeft, S; Hudde, T; Neudorf, U; Steuhl, KP | 1 |
Beaufils, H; Deray, G; Isnard Bagnis, C; Jaudon, MC; Jouanneau, C; LeHoang, P; Maksud, P; Mallet, A; Tezenas du Montcel, S | 1 |
Cusmai, A; Dammacco, R; Frassanito, MA; Fusaro, T; Guerriero, S; Sborgia, C | 1 |
Androudi, S; Brazitikos, P; Christen, W; Fiore, T; Foster, CS; Iaccheri, B; Meniconi, M | 1 |
Büscher, R; Hoyer, PF; Hudde, T; Vester, U; Vij, O | 1 |
Pleyer, U; Schmidt, S | 1 |
Pleyer, U | 1 |
Gül, A; Inanc, M; Kamali, S; Kasapoglu, E; Mudun, A; Tugal-Tutkun, I; Urgancioglu, M | 1 |
Dong, XG; Shi, WY; Wang, SG; Xie, LX; Xu, YM; Yuan, GQ | 1 |
Dong, X; Lin, P; Shi, W; Wang, S; Xie, L; Yuan, G | 1 |
Barbera, L; Mora, P; Orsoni, JG; Toscani, M; Vecchi, M | 1 |
He, Y; Liu, YL; Ma, ZZ; Wang, JC; Zhang, Q; Zhu, XA | 1 |
He, Y; Liu, Y; Lu, W; Ma, Z; Wang, J; Zhang, Q; Zhang, X; Zhu, X | 1 |
Balbaba, M; Demir, N; Demir, T; Gödekmerdan, A; Ilhan, F; Türkçüoglu, P | 1 |
Bagnis, CI; Bodaghi, B; Deray, G; du Montcel, ST; Jaudon, MC; Le Hoang, P; Mallet, A; Tostivint, I | 1 |
Dick, AD; Hogan, AC; Lee, RW; McAvoy, CE | 1 |
Bang, D; Bodaghi, B; Chamberlain, AM; Gul, A; Hatemi, G; Houman, MH; Kötter, I; Olivieri, I; Salvarani, C; Sfikakis, PP; Silman, A; Siva, A; Stanford, MR; Stübiger, N; Yazici, H; Yurdakul, S | 1 |
Aldigeri, R; Carta, A; Ceglarek, U; Manzotti, F; Mora, P; Orsoni, JG; Zavota, L | 1 |
Benchekroun, N; Berraho-Hamani, A; Chaoui, Z; el Aouni, A; Hajji, Z; Ouazzani, B | 1 |
Ashton, P; Blandford, DL; Jaffe, GJ; Martin, DF; Nussenblatt, RB; Pearson, PA | 1 |
Boguszaková, J; Havlíková, M; Michalová, K; Poch, T; Ríhová, E | 1 |
Chan, CC; DeBarge, LR; Martin, DF; Nussenblatt, RB; Roberge, FG | 1 |
Lang, LS; Robertson, SM | 1 |
Bianchi, E; Carone, M; Castellino, P; d'Alessio, O; de Pascale, E; Giordano, M; Luzi, L; Pluvio, C; Vergani, S | 1 |
Fernandez Lucas, M; Gonzalo, A; Orte, L; Ortuño, J; Quereda, C; Sabater, J; Soria, C | 1 |
Nussenblatt, RB; Salvo, EC; Whitcup, SM | 1 |
Bambara, LM; Biasi, D; Botto, M; Caramaschi, P; Cortina, P; Girelli, D; Lombardo, G; Lunardi, C; Pacor, ML; Urbani, G | 1 |
Aresu, G; Barca, L; Frongia, T; Pascalis, L; Pia, G | 1 |
Lee, FD; Morris, AJ; Murphy, EA; Sturrock, RD; Walker, E | 1 |
de Smet, MD; Nussenblatt, RB | 1 |
Bechtel, U; Feucht, HE; Lund, OE; Thurau, SR | 1 |
Bloom, JN; Davis, J; de Smet, MD; Freidlin, V; Herman, D; Nussenblatt, RB; Rubin, B; Sran, PK; Whitcher, S; Whitcup, SM | 1 |
Foster, CS; Rodriguez, A; Vitale, AT | 1 |
Fukushima, A; Gery, I; Nussenblatt, RB; Whitcup, SM | 1 |
Matthews, AG | 1 |
Champagne, ES; Gratzek, AT; Kaswan, RL; Martin, CL; White, SL | 1 |
Ashton, P; Enyedi, LB; Jaffe, GJ; Pearson, PA | 1 |
Neidhart, M | 1 |
Cantarovich, M; Deschênes, J; Rocha, G | 1 |
Nussenblatt, RB; Whitcup, SM | 1 |
de Smet, MD; Nussenblatt, RB; Ramadan, AM | 1 |
Mochizuki, M | 1 |
Nussenblatt, RB | 1 |
Dick, AD; Forrester, JV; Kreutzer, B; Laliotou, B | 1 |
Akyol, N; Değer, O; Erdöl, H; Gedik, Y; Imamoglu, HI; Orem, A | 1 |
Epstein, RJ; Hendricks, RL; Lipman, RM | 1 |
Dick, AD; Forrester, JV; Kilmartin, DJ | 1 |
Goto, H; Kezuka, T; Matuura, G; Usui, M; Yamakawa, N | 1 |
ten Hoopen-Neumann, H; van der Meijden, WI; van Hagen, PM | 1 |
Fortin, E; Goldman, CK; Nussenblatt, RB; Rizzo, L; Schiffman, R; Smith, J; Sran, P; Van Veldhuisen, P; Waldmann, TA; Whitcup, SM; Yaffe, A | 1 |
Kaplan, HJ; Van Gelder, RN | 1 |
BenEzra, D; Cohen, E; Maftzir, G | 1 |
Allen, JB; Ashton, P; Gilger, BC; Horohov, D; Jaffe, GJ; Malok, E; Smith, T; Stewart, T | 1 |
Kulkarni, P | 1 |
Bimstein, E; Irshied, J | 1 |
Allen, JB; Davidson, MG; Gilger, BC; Wilkie, DA | 1 |
Bondartschuk, K; Fricke, B; Friedrich, R; Illéssy, A; Klein, S | 1 |
Aguilera, S; Benhmida, M; Deray, G; Desjobert, H; Jacobs, C; Le Hoang, P | 1 |
Farinelli, R; Fiocchi, O; Malacarne, F; Nunzi, L; Scaramuzzo, P; Scorrano, R; Tataranni, G; Zavagli, G | 1 |
Nussenblatt, R | 1 |
Aupetit, B; Baumelou, A; Benhmida, M; Deray, G; Jacobs, C; Le Hoang, P; Maksud, P | 1 |
Feutren, G; Mihatsch, MJ | 1 |
Austin, HA; de Smet, MD; Lopez, JS; Nussenblatt, RB; Rubin, BI; Whitcup, SM | 1 |
Kawashima, H; Mochizuki, M | 1 |
Chan, CC; Mochizuki, M; Ni, M; Nussenblatt, RB | 1 |
Hirose, S; Matsuda, H; Ohno, S; Onoé, K; Sasamoto, Y | 1 |
McCluskey, P; Wakefield, D | 1 |
Buskila, D; Shoenfeld, Y; Sukenik, S | 1 |
Bragliani, G; Catarinelli, G; De Molfetta, V; De Rosa, C; Latanza, L; Pivetti-Pezzi, P; Rossi, A; Scorrano, R; Secchi, AG; Tognon, S | 1 |
Fujino, Y; Higashihara, E; Horiuchi, D; Inaba, G; Kaku, H; Kawashima, H; Mochizuki, M; Okumura, A; Tange, T | 1 |
Caspi, RR; Gery, I; McAllister, CG; Nussenblatt, RB | 1 |
Fujino, Y; Higashihara, E; Horiuchi, D; Kawashima, H; Mochizuki, M; Okumura, A; Tange, T | 1 |
Dinning, WJ; Kuwabara, T; Leake, W; Nussenblatt, RB | 1 |
16 review(s) available for cyclosporine and Uveitis
Article | Year |
---|---|
Cyclosporine A Delivery Platform for Veterinary Ophthalmology-A New Concept for Advanced Ophthalmology.
Topics: Animals; Cyclosporine; Cytokines; Horses; Humans; Immunosuppressive Agents; Keratitis; Ophthalmology; Uveitis; Water | 2022 |
Current standardized therapeutic approach for uveitis in Japan.
Topics: Adalimumab; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Japan; Uveitis | 2019 |
Treatment of chronic non-infectious uveitis and scleritis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Scleritis; Uveitis | 2019 |
Ocular Inflammation: Can It Be a Sign of Activity of Weber-Christian Disease? A Case Report and Review of Literature.
Topics: Cataract Extraction; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Panniculitis, Nodular Nonsuppurative; Retinal Vasculitis; Uveitis; Visual Acuity; Young Adult | 2016 |
Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
Topics: Adrenal Cortex Hormones; Adult; Behcet Syndrome; Cyclosporine; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Infliximab; Male; Renal Dialysis; Treatment Outcome; Uveitis; Visual Acuity | 2015 |
Cyclosporine: A Historical Perspective on Its Role in the Treatment of Noninfectious Uveitis.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Uveitis | 2017 |
Review: implants.
Topics: Animals; Cyclosporine; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Implants; Filtering Surgery; Fluorouracil; Ganciclovir; Glaucoma; Humans; Uveitis | 1994 |
Clinical use of cyclosporine in ocular disease.
Topics: Autoimmune Diseases; Cyclosporine; Eye Diseases; Humans; Ophthalmic Solutions; Uveitis | 1993 |
Immunologic mechanisms of uveitis. New targets for immunomodulation.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antibodies, Monoclonal; Cell Adhesion Molecules; Cyclosporine; Humans; Immune Tolerance; Immunosuppressive Agents; Uveitis | 1997 |
Immunotherapy for Behçet's disease.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents; Behcet Syndrome; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Immunotherapy; Ligands; Tacrolimus; Uveitis | 1997 |
Uveitis in Behçet's disease.
Topics: Adrenal Cortex Hormones; Anterior Eye Segment; Behcet Syndrome; Cataract; Colchicine; Cyclosporine; Humans; Tacrolimus; Uveitis; Vitreous Body | 1997 |
Immunosuppression in uveitis therapy.
Topics: Administration, Oral; Administration, Topical; Animals; Arrestin; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rats; Steroids; Tacrolimus; Uveitis | 1999 |
Prediction of treatment outcome in uveitis.
Topics: Cells, Cultured; Cyclosporine; Humans; Immunosuppressive Agents; Lymphocytes; Prognosis; Treatment Outcome; Uveitis | 1999 |
Review: uveitis and immunosuppressive drugs.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Sirolimus; Tacrolimus; Uveitis | 2001 |
The expanding use of immunosuppression in the treatment of non-infectious ocular disease.
Topics: Bromocriptine; Corneal Transplantation; Cyclosporine; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Humans; Immunosuppression Therapy; Keratoconjunctivitis; Prednisone; Uveitis | 1992 |
The possible role of prolactin in autoimmunity.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Arthritis, Psoriatic; Autoantibodies; Autoimmune Diseases; Autoimmunity; Bromocriptine; Cyclosporine; Drug Synergism; Female; Humans; Hyperprolactinemia; Immunity, Cellular; Immunocompetence; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Pregnancy; Pregnancy Complications; Prolactin; Rats; Rheumatic Diseases; Uveitis | 1991 |
18 trial(s) available for cyclosporine and Uveitis
Article | Year |
---|---|
An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet's disease in long-term remission.
Topics: Behcet Syndrome; Cyclosporine; Humans; Infliximab; Prospective Studies; Treatment Outcome; Uveitis | 2021 |
Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.
Topics: Adult; Cyclosporine; Diltiazem; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Remission Induction; Uveitis; Vasodilator Agents | 2017 |
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
Topics: Adult; Chronic Disease; Cyclosporine; Everolimus; Female; Flow Cytometry; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Photometry; Pilot Projects; Prospective Studies; Recurrence; Sirolimus; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2013 |
Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
Topics: Adult; Atrophy; Cohort Studies; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrosis; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Tubules; Male; Middle Aged; Prospective Studies; Uveitis | 2002 |
[Cyclosporine monitoring in patients with chronic uveitis].
Topics: Adolescent; Adult; Biological Availability; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Uveitis | 2005 |
[Intraocular inflammations. A diagnostic and therapeutic challenge].
Topics: Antiviral Agents; Behcet Syndrome; Chronic Disease; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Prognosis; Recombinant Proteins; Uveitis; Vision, Low | 2005 |
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retreatment; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis | 2005 |
Renal outcome after ciclosporin-induced nephrotoxicity.
Topics: Adult; Aged; Blood Glucose; Colorimetry; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Prognosis; Prospective Studies; Uric Acid; Uveitis | 2007 |
[Initial experience with therapy of endogenous uveitis with Consupren--the Czech cyclosporin A].
Topics: Adult; Cyclosporine; Female; Humans; Male; Uveitis | 1994 |
Renal hemodynamic effects of cyclosporine treatment in patients with chronic uveitis and normal native kidneys.
Topics: Adult; Amino Acids; Blood Pressure; Cyclosporine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Glucagon; Hemodynamics; Humans; Insulin; Kidney; Male; Middle Aged; Uveitis; Vascular Resistance | 1994 |
Low-dose cyclosporine A nephrotoxicity in non-renal patients.
Topics: Administration, Oral; Adult; Analysis of Variance; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Kidney; Male; Middle Aged; Prospective Studies; Psoriasis; Uveitis | 1994 |
Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.
Topics: Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Male; Time Factors; Treatment Outcome; Uveitis; Visual Acuity | 1994 |
Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.
Topics: Adolescent; Adult; Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Methotrexate; Middle Aged; Uveitis; Visual Acuity | 1993 |
A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious origin.
Topics: Adult; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Prednisone; Uveitis; Vision Disorders; Visual Acuity | 1993 |
Long-term follow-up of patients with chronic uveitis affecting the posterior pole treated with combination cyclosporine and ketoconazole.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Ketoconazole; Longitudinal Studies; Middle Aged; Pilot Projects; Prednisone; Prospective Studies; Uveitis | 1997 |
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Immunotherapy; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Prednisone; Th1 Cells; Treatment Outcome; Uveitis | 1999 |
Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis.
Topics: Autoimmune Diseases; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glomerular Filtration Rate; Humans; Ketoconazole; Uveitis | 1992 |
Open noncontrolled multicenter long-term trial with ciclosporin in endogenous non-infectious uveitis.
Topics: Adult; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Uveitis; Visual Acuity | 1991 |
86 other study(ies) available for cyclosporine and Uveitis
Article | Year |
---|---|
Ciclosporin A in bilateral auto-immune chronic posterior uveitis associated with macular oedema: a Long-term Observational Safety and Efficacy Study.
Topics: Creatinine; Cyclosporine; Follow-Up Studies; Humans; Macular Edema; Retrospective Studies; Uveitis; Uveitis, Posterior | 2022 |
Insights gained from Single-Cell analysis of immune cells on Cyclosporine A treatment in autoimmune uveitis.
Topics: Animals; Autoimmune Diseases; Cyclosporine; Disease Models, Animal; Mice; Single-Cell Analysis; Th17 Cells; Uveitis | 2022 |
Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Topics: Acute Disease; Adrenal Cortex Hormones; Cyclosporine; Female; Humans; Inflammation; Male; Pregnancy; Retrospective Studies; Uveitis; Uveomeningoencephalitic Syndrome | 2023 |
Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis following Cyclosporine for Uveitis.
Topics: Cyclosporine; Epstein-Barr Virus Infections; Eye Infections, Viral; Fluorescein Angiography; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Microscopy, Acoustic; Middle Aged; Uveitis | 2020 |
Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Humans; Immunomodulation; Uveitis; Uveomeningoencephalitic Syndrome | 2020 |
Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis.
Topics: Animals; Autoimmune Diseases; Conditioning, Classical; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Male; Mice; Neuroimmunomodulation; Th17 Cells; Uveitis | 2017 |
Cyclosporine A-Loaded Nanocarriers for Topical Treatment of Murine Experimental Autoimmune Uveoretinitis.
Topics: Administration, Ophthalmic; Animals; Autoimmune Diseases; Cyclosporine; Disease Models, Animal; Drug Carriers; Eye Proteins; Female; Humans; Immunosuppressive Agents; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Retinol-Binding Proteins; Treatment Outcome; Uveitis | 2018 |
Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes.
Topics: Administration, Topical; Animals; Aqueous Humor; Cyclosporine; Drug Carriers; Eye; Immunosuppressive Agents; Lipopolysaccharides; Male; Polyesters; Rabbits; Uveitis | 2019 |
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Treatment Failure; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2014 |
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience.
Topics: Adult; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; HLA-B51 Antigen; Humans; Immunosuppressive Agents; Infliximab; Interferon-alpha; Macular Edema; Male; Middle Aged; Mycophenolic Acid; Prevalence; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis; Visual Acuity | 2015 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD20; Audiometry; Cyclosporine; Dexamethasone; Female; Hearing Loss; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Panuveitis; Prednisolone; Prednisone; Prognosis; Recurrence; Remission Induction; Rituximab; Uveitis; Uveomeningoencephalitic Syndrome | 2015 |
Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.
Topics: Adult; Antibodies, Monoclonal; Cells, Cultured; Cyclosporine; Cytokines; Dexamethasone; Disease Progression; Female; Forkhead Transcription Factors; Humans; Infliximab; Lymphocyte Count; Male; Middle Aged; T-Lymphocytes, Regulatory; Uveitis; Young Adult | 2015 |
[Therapy of intermediate uveitis].
Topics: Adrenal Cortex Hormones; Combined Modality Therapy; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Intravitreal Injections; Treatment Outcome; Uveitis | 2014 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
[Uveitic macular edema and the pharmacotherapy].
Topics: Acetazolamide; Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Azathioprine; Bevacizumab; Cyclosporine; Humans; Immunosuppressive Agents; Macular Edema; Methotrexate; Mycophenolic Acid; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders | 2015 |
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Topics: Adult; Behcet Syndrome; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Recurrence; Remission Induction; Treatment Outcome; Turkey; Uveitis; Visual Acuity | 2015 |
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Topics: Adalimumab; Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Retreatment; Retrospective Studies; Sarcoidosis; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Young Adult | 2015 |
BIRC4 Mutation: An Important Rare Cause of Uveitis.
Topics: Adalimumab; Antirheumatic Agents; Child; Cyclosporine; Epstein-Barr Virus Infections; Genetic Diseases, X-Linked; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Mutation; Treatment Outcome; Uveitis; X-Linked Inhibitor of Apoptosis Protein | 2015 |
[Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Topics: Animals; Autoimmune Diseases; Cyclosporine; Down-Regulation; Eye Proteins; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Isoxazoles; Leflunomide; Random Allocation; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; RNA, Messenger; Th17 Cells; Uveitis | 2015 |
Interferon Alpha-2a Therapy in Patients with Refractory Behçet Uveitis.
Topics: Adolescent; Adult; Azathioprine; Behcet Syndrome; Child; Cyclosporine; Drug Combinations; Drug Resistance; Female; Fluorescein Angiography; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Tomography, Optical Coherence; Uveitis; Visual Acuity | 2017 |
Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
Topics: Adult; Aged; Azathioprine; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Klebsiella Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pneumocystis Infections; Prednisolone; Retrospective Studies; Uveitis | 2018 |
Robert Burton Nussenblatt, MD, MPH (1948-2016), Physician-Scientist, Leading Ophthalmologist and Exemplary Teacher.
Topics: Antibodies, Monoclonal, Humanized; Cyclosporine; Daclizumab; Eye Diseases; History, 20th Century; History, 21st Century; Humans; Immunoglobulin G; Immunosuppressive Agents; National Eye Institute (U.S.); Ophthalmologists; Physicians; United States; Uveitis | 2017 |
Special Issue in Honor of Robert B. Nussenblatt, MD, MPH.
Topics: Cyclosporine; Eye Diseases; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; National Eye Institute (U.S.); Ophthalmologists; Physicians; T-Lymphocytes; United States; Uveitis | 2017 |
Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies; Uveitis | 2009 |
LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.
Topics: Animals; Autoimmune Diseases; Cyclosporine; Cytokines; Disease Models, Animal; Eye Proteins; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Lymphocyte Activation; Male; Rats; Rats, Inbred Lew; Retinitis; Retinol-Binding Proteins; T-Lymphocytes; Treatment Outcome; Uveitis | 2009 |
Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report.
Topics: Abatacept; Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoconjugates; Infusions, Intravenous; Prednisone; Treatment Outcome; Uveitis; Visual Acuity | 2008 |
Gout attack with unusual ocular complications.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Colchicine; Cyclosporine; Diuretics; Edema; Gout; Gout Suppressants; Humans; Intraocular Pressure; Male; Middle Aged; Optic Disk; Prednisolone; Trabeculectomy; Treatment Outcome; Uveitis | 2009 |
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Behcet Syndrome; Cyclosporine; Drug Evaluation; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2010 |
Cyclosporine for ocular inflammatory diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Pemphigoid, Benign Mucous Membrane; Retrospective Studies; Scleritis; Treatment Outcome; Uveitis; Young Adult | 2010 |
[Systemic voclosporin for uveitis treatment].
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intra-Arterial; Randomized Controlled Trials as Topic; Treatment Outcome; Uveitis | 2010 |
Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis.
Topics: Animals; Cyclosporine; Female; Horse Diseases; Horses; Immunosuppressive Agents; Infusion Pumps, Implantable; Male; Uveitis | 2010 |
Induction of regulatory T cells by infliximab in Behcet's disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Cyclosporine; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Forkhead Transcription Factors; Humans; Infliximab; T-Lymphocytes, Regulatory; Toxoplasmosis, Ocular; Tumor Necrosis Factor-alpha; Uveitis; Uveomeningoencephalitic Syndrome | 2011 |
Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aqueous Humor; Behcet Syndrome; Cyclosporine; Cytokines; Female; HLA-B27 Antigen; Humans; Interferon-gamma; Interleukin-10; Interleukin-15; Interleukin-17; Logistic Models; Male; Middle Aged; Th1 Cells; Th17 Cells; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Uveomeningoencephalitic Syndrome; Young Adult | 2011 |
Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Azathioprine; Cataract; Cataract Extraction; Cyclosporine; Expert Testimony; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Macular Edema; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Ophthalmologic Surgical Procedures; Surveys and Questionnaires; Uveitis; Young Adult | 2011 |
Clinical outcomes of cyclosporine treatment for noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Prednisolone; Republic of Korea; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity | 2012 |
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Glucocorticoids; Humans; Injections, Subcutaneous; Macula Lutea; Male; Methotrexate; Off-Label Use; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2012 |
Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Behcet Syndrome; Colchicine; Cyclosporine; Female; Glucocorticoids; Humans; Infliximab; Infusions, Intravenous; Male; Middle Aged; Retinitis; Retrospective Studies; Uveitis; Visual Acuity; Young Adult | 2012 |
A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Cataract Extraction; Cyclosporine; Disease Models, Animal; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Lactic Acid; Lens Implantation, Intraocular; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Triamcinolone Acetonide; Uveitis | 2013 |
[Tubulointerstitial nephritis and uveitis (TINU syndrome) - comorbidity and complications in four patients].
Topics: Adolescent; Arthritis, Rheumatoid; Autoimmune Diseases; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Mycophenolic Acid; Nephritis, Interstitial; Patient Care Team; Syndrome; Thyroiditis, Autoimmune; Treatment Outcome; Uveitis | 2002 |
Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-gamma production and the function of dendritic cells.
Topics: Adult; Chronic Disease; Cyclosporine; Dendritic Cells; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunophenotyping; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Prednisone; Th1 Cells; Uveitis | 2003 |
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
Topics: Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Retrospective Studies; Treatment Outcome; Uveitis | 2003 |
Pseudotumor cerebri following cyclosporine A treatment in a boy with tubulointerstitial nephritis associated with uveitis.
Topics: Adrenal Cortex Hormones; Child; Cyclosporine; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mycophenolic Acid; Nephritis, Interstitial; Pseudotumor Cerebri; Tomography, X-Ray Computed; Uveitis | 2004 |
[Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
Topics: Animals; Cyclosporine; Drug Delivery Systems; Drug Implants; Female; Immunosuppressive Agents; Male; Rabbits; Random Allocation; Uveitis; Vitreous Body | 2005 |
Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
Topics: Absorbable Implants; Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Female; Immunosuppressive Agents; Male; Polyesters; Rabbits; Uveitis; Vitreous Body | 2006 |
Use of systemic cyclosporin A in a case of severe Toxocara uveitis.
Topics: Adult; Animals; Cyclosporine; Female; Humans; Immunosuppressive Agents; Toxocara canis; Toxocariasis; Uveitis | 2006 |
Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
Topics: Animals; Aqueous Humor; Biocompatible Materials; Cyclosporine; Disease Models, Animal; Drug Carriers; Electroretinography; Eye; Immunosuppressive Agents; Injections; Lactic Acid; Leukocyte Count; Leukocytes; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Solubility; Uveitis | 2006 |
Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
Topics: Animals; Biocompatible Materials; Chromatography, High Pressure Liquid; Cyclosporine; Drug Carriers; Immunosuppressive Agents; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Phase-Contrast; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Surface Properties; Uveitis; Vitreous Body | 2006 |
The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arrestin; Autoimmune Diseases; Biomarkers; Cyclosporine; Cytokines; Disease Models, Animal; Follow-Up Studies; Immunosuppressive Agents; Infliximab; Injections, Intraperitoneal; Interleukin-10; Male; Rats; Rats, Inbred Lew; Recombinant Proteins; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Vitreous Body | 2006 |
Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome; Uveitis | 2007 |
EULAR recommendations for the management of Behçet disease.
Topics: Anticoagulants; Arthritis; Behcet Syndrome; Cyclosporine; Evidence-Based Medicine; Gastrointestinal Diseases; Humans; International Cooperation; Nervous System Diseases; Skin Diseases; Uveitis; Vascular Diseases | 2008 |
Cyclosporin A in the ocular fluids of uveitis patients following long-term systemic administration.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aqueous Humor; Autoimmune Diseases; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lens Capsule, Crystalline; Male; Middle Aged; Tandem Mass Spectrometry; Tears; Uveitis | 2008 |
[Outcome of Behçet disease in ophthalmologic practice in Morocco].
Topics: Adult; Behcet Syndrome; Chlorambucil; Cyclosporine; Eye Diseases; Female; Humans; Male; Morocco; Prednisone; Prognosis; Retinal Diseases; Time Factors; Uveitis | 1995 |
Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Drug Synergism; Eye Proteins; Immunosuppressive Agents; Lymph Nodes; Lymphocyte Activation; Male; Polyenes; Rats; Rats, Inbred Lew; Retinitis; Sirolimus; Uveitis | 1995 |
Leflunomide: inhibition of S-antigen induced autoimmune uveitis in Lewis rats.
Topics: Administration, Oral; Administration, Topical; Animals; Antibodies; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Dexamethasone; Dose-Response Relationship, Drug; Eye Proteins; Freund's Adjuvant; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Retina; Uveitis | 1994 |
Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Male; Middle Aged; Prednisone; Uveitis; Visual Acuity | 1994 |
Cyclosporine A induced colitis and acquired selective IgA deficiency in a patient with juvenile chronic arthritis.
Topics: Arthritis, Juvenile; Child; Colitis; Cyclosporine; Female; Humans; IgA Deficiency; Naproxen; Uveitis | 1993 |
[Comments on the contribution by S. Klein et al. Cyclosporin A in therapy of chronic uveitis].
Topics: Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Metabolic Clearance Rate; Uveitis | 1993 |
Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Ophthalmic Solutions; Prednisone; Retrospective Studies; Uveitis; Visual Acuity | 1996 |
Effects of cyclosporin A on the induction of oral tolerance.
Topics: Administration, Oral; Animals; Antigens; Arrestin; Autoantigens; Autoimmune Diseases; Clonal Anergy; Cyclosporine; Eye Proteins; Immune Tolerance; Immunity, Cellular; Immunosuppressive Agents; Lymphocyte Activation; Male; Rats; Rats, Inbred Lew; Uveitis | 1996 |
Cyclosporine A and the equine cornea.
Topics: Animals; Cornea; Corneal Diseases; Cyclosporine; Horse Diseases; Horses; Uveitis | 1995 |
Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Cornea; Corneal Ulcer; Cyclosporine; Female; Glaucoma; Horse Diseases; Horses; Immunosuppressive Agents; Keratitis; Male; Retrospective Studies; Uveitis | 1995 |
An intravitreal device providing sustained release of cyclosporine and dexamethasone.
Topics: Animals; Cataract; Cyclosporine; Dexamethasone; Drug Implants; Female; Male; Rabbits; Time Factors; Uveitis; Vitreoretinopathy, Proliferative; Vitreous Body | 1996 |
Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats.
Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; Bromocriptine; Cyclosporine; Delayed-Action Preparations; Diabetes Mellitus, Type 1; Drug Synergism; Female; Male; Ornithine Decarboxylase; Polyarteritis Nodosa; Rats; Rats, Inbred BB; Rats, Inbred Lew; Rats, Sprague-Dawley; Thymus Gland; Uveitis | 1996 |
Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis.
Topics: Adult; Aged; Creatine; Cyclosporine; Drug Monitoring; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Recurrence; Technetium Tc 99m Pentetate; Uveitis | 1997 |
Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration.
Topics: Administration, Intranasal; Animals; Antigens; Autoimmune Diseases; Cattle; Chemotaxis, Leukocyte; Choroid; Cyclosporine; Drug Therapy, Combination; Eye Proteins; Female; Flow Cytometry; Granulocytes; Immunophenotyping; Leukocyte Count; Macrophages; Rats; Rats, Inbred Lew; Retina; T-Lymphocytes; Uveitis | 1997 |
The importance of plasma polymorphonuclear (PMN) elastase determination in patients with uveitis.
Topics: Adolescent; Adult; Biomarkers; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Treatment Outcome; Uveitis | 1997 |
Cyclosporine and neovascularization.
Topics: Animals; Corneal Neovascularization; Cyclosporine; Mice; T-Lymphocytes; Uveitis | 1999 |
Cyclosporin A therapy in refractory non-infectious childhood uveitis.
Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity | 1998 |
[Suppression of experimental autoimmune uveoretinitis with a combination of cyclosporin and allopurinol].
Topics: Allopurinol; Animals; Autoimmune Diseases; Cyclosporine; Free Radical Scavengers; Immunosuppressive Agents; Male; Rats; Rats, Inbred Lew; Retinitis; Uveitis; Xanthine Oxidase | 1999 |
[Behcet's disease].
Topics: Adult; Behcet Syndrome; Colchicine; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Prednisone; Sexually Transmitted Diseases; Stomatitis, Aphthous; Treatment Outcome; Uveitis; Vulvar Diseases | 1999 |
Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.
Topics: Animals; Aqueous Humor; Cyclosporine; Drug Implants; Horse Diseases; Horses; Immunohistochemistry; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Count; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Uveitis | 2000 |
Oral diagnosis of Behcet disease in an eleven-year old girl and the non-surgical treatment of her gingival overgrowth caused by Cyclosporine.
Topics: Behcet Syndrome; Child; Cyclosporine; Dental Plaque; Dental Prophylaxis; Diagnosis, Differential; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Overgrowth; Gingivitis; Humans; Immunosuppressive Agents; Oral Hygiene; Patient Care Planning; Treatment Outcome; Uveitis | 2001 |
Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis.
Topics: Animals; Cyclosporine; Delayed-Action Preparations; Electroretinography; Female; Horse Diseases; Horses; Immunosuppressive Agents; Male; Uveitis | 2001 |
[Cyclosporin A in therapy of chronic uveitis].
Topics: Administration, Oral; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Recurrence; Uveitis | 1992 |
Effects of cyclosporine on tubular acidification function in patients with idiopathic uveitis.
Topics: Acidosis, Renal Tubular; Adult; Aged; Aldosterone; Bicarbonates; Carbon Dioxide; Cyclosporine; Electrolytes; Female; Humans; Hydrogen-Ion Concentration; Kidney Tubules; Male; Middle Aged; Osmolar Concentration; Potassium; Sodium; Sodium Bicarbonate; Urine; Uveitis | 1992 |
Usefulness of the assessment of urinary enzymes and microproteins in monitoring ciclosporin nephrotoxicity.
Topics: Acetylglucosaminidase; Adolescent; Adult; beta 2-Microglobulin; Biomarkers; Cyclosporine; Female; gamma-Glutamyltransferase; Humans; Kidney; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Proteinuria; Reference Values; Uveitis | 1992 |
Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis.
Topics: Adult; Autoimmune Diseases; Cholesterol; Creatinine; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Potassium; Triglycerides; Uric Acid; Uveitis | 1992 |
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
Topics: Adolescent; Adult; Age Factors; Autoimmune Diseases; Blood Pressure; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Psoriasis; Retrospective Studies; Risk Factors; Sjogren's Syndrome; Uveitis | 1992 |
Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat.
Topics: Animals; Antibodies; Antigens; Arrestin; Autoimmune Diseases; Body Weight; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Eye; Eye Proteins; Guanidines; Immunosuppressive Agents; Male; Rats; Rats, Inbred Lew; Tacrolimus; Uveitis | 1990 |
FR900506 (FK506) and 15-deoxyspergualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveoretinitis.
Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Eye Proteins; Guanidines; Immunoenzyme Techniques; Immunosuppressive Agents; Macrophages; Male; Rats; Rats, Inbred Lew; Retina; T-Lymphocyte Subsets; Tacrolimus; Uveitis | 1990 |
Topical application of ciclosporin ophthalmic solution containing alpha-cyclodextrin in experimental uveitis.
Topics: Administration, Topical; alpha-Cyclodextrins; Animals; Antigens; Arrestin; Cyclodextrins; Cyclosporine; Disease Models, Animal; Drug Carriers; Eye Proteins; Male; Ophthalmic Solutions; Phosphodiesterase Inhibitors; Rabbits; Rats; Rats, Inbred Lew; Retinol-Binding Proteins; Uveitis; Vitreous Body | 1991 |
Cyclosporine: a therapy in inflammatory eye disease.
Topics: Adult; Aged; Arthritis, Reactive; Blood Pressure; Creatinine; Cyclosporine; Eye Diseases; Female; Follow-Up Studies; Hirsutism; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Treatment Outcome; Tremor; Uveitis; Uveomeningoencephalitic Syndrome; Visual Acuity | 1991 |
Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
Topics: Animals; Antibody Formation; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Cyclosporins; Eye Proteins; Immunity, Cellular; Kidney; Kidney Function Tests; Male; Rats; Rats, Inbred Lew; Retinitis; Skin Tests; Uveitis | 1989 |
Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cyclosporine; Cyclosporins; Eye Proteins; Immunosuppression Therapy; Interleukin-1; Interleukin-2; Lymphocyte Activation; Lymphocyte Cooperation; Pineal Gland; Rats; Rats, Inbred Lew; Receptors, Immunologic; Receptors, Interleukin-2; Recombinant Proteins; Retinitis; T-Lymphocytes, Helper-Inducer; Uveitis | 1988 |
[The effects of cyclosporine G and D treatment on experimental autoimmune uveoretinitis and kidney in rats].
Topics: Animals; Autoimmune Diseases; Cyclosporine; Cyclosporins; Kidney; Rats; Rats, Inbred Lew; Retinitis; Uveitis | 1987 |
The induction of tolerance by cyclosporine-G in experimental autoimmune uveitis in the Lewis rat.
Topics: Animals; Antigens; Arrestin; Autoimmune Diseases; Cell Division; Cyclosporine; Cyclosporins; Eye Proteins; Female; Immune System; Immune Tolerance; Lymph Nodes; Rats; Rats, Inbred Lew; Uveitis | 1987 |